This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Ebola: Managing to Save Lives
IESE InsightArticle ART-2676-EService and Operations ManagementA year after the outbreak of Ebola in West Africa in March 2014, health-care experts are cautiously optimistic that the epidemic appears to be slowing. Although the outlook is brighter than a year ago when the first case was detected in Guinea, there is still a long way to go and many lessons to be learned in managing a crisis of this scale, related to institutional shortfalls, international coordination, engagement with local stakeholders and, m...Starting at €8.20
-
Monnikenheide
Mei Qi; Lieven DemeesterCase IVEY-9B13D020-EEntrepreneurship, Leadership and People Management, Service and Operations Management, StrategyFounded in 1973 with a vision of inclusion, integration and normalization, Monnikenheide had pioneered a series of innovative approaches to improve the quality of life of people with mental disabilities. It had introduced some of its practices to local partners in China, India and Indonesia and now had the most sought-after facilities in Belgium for families with special-needs children and other family members. At the age of 69, the co-founder of...Starting at €8.20
-
AGROESSA: An LP Optimization Model for Coffee Sales in La Esperanza AgroIndustrial
de Waal P. N.; Baucells Alibés, ManelCase AD-299-EService and Operations ManagementRufino Herrera, the president of AGROESSA, was pondering the implications of the recommendations which came out of the work of Nico de Waal, an MBA student who worked for AGROESSA as a summer intern in 2004. The recommendations focussed on AGROESSA's cash flow management during the coffee harversting season. It was argued that AGROESSA could improve its profits by carefully considering when and to which market it should sell its coffee production...Starting at €8.20
-
Tiburon
John S. Haywood-Farmer; Sean CautermanCase IVEY-9B09D003-EEntrepreneurship, Service and Operations Management, StrategyIn April, 2008, the president of Tiburon, a manufacturer of camouflage components based in the Dominican Republic, met with Tiburon's parent company and sole customer, GMA. GMA, based in Guelph, Ontario, was an equipment supplier to the United States Army. Tiburon had only been in business one month, and the president was analyzing the current production process in each of the Dominican and Guelph plants. There were noted differences between the ...Starting at €8.20
-
Ébola: cuando una buena gestión salva vidas
IESE InsightArticle ART-2676Service and Operations ManagementEl ébola se ha cobrado más de diez mil víctimas en apenas un año y durante varios meses la epidemia amenazó con extenderse sin control por todo el mundo. ¿Cuáles han sido los principales errores y escollos en la gestión de la crisis?Starting at €8.20
-
ITT Automotive: Global Manufacturing Strategy--1994 (Spanish Version)
Pisano, Gary P.; Rossi, SharonCase HBS-603S10Service and Operations ManagementITT Automotive está en el proceso de desarrollar un sistema de nueva generación de frenos antibloqueo (ABS), designado el MK-20. El caso se centra en el nivel de automatización que se utilizan en la producción de este nuevo sistema, y si todas las plantas deben utilizar la misma tecnología de proceso. Debido a la intensificación de la presión de costes y creciente demanda de menor costo ABS, el equipo de desarrollo y la administración superior ...Starting at €8.20
-
Bill & Melinda Gates Foundation: Shaping the Vaccine Manufacturing Ecosystem
Shih, WillyCase HBS-620021-EService and Operations ManagementVaccines for children has been a long-standing focus for the Bill & Melinda Gates Foundation, and their critical role in public health made their production an important economic and political issue. This case describes the Foundation's investment in a breakthrough vaccine manufacturing platform for the Sabin inactivated polio virus. While the new technology promised a much lower cost per dose, it also raised questions about the consequences of l...Starting at €8.20